To explore the curative options for children with β-thalassemia major(β-TM)and to improve the prognosis and survival of these children,we retrospectively report the clinical data,diagnostic,and therapeutic procedures of a child with β-TM.The child,a female,aged 5 years and 9 months,was diagnosed with β-TM at another hospital when she was three months old,and was treated with blood transfusion and iron chelation therapy for the symptomatic treatment.The parents gave birth to a second child by preimplantation genetic testing with HLA matching(PGT-HLA)and successfully performed cord blood transplantation for the child.
维普
万方数据